Key Insights from the 2025 Fall Clinical PA/NP Meeting: Day 3 Highlights

On June 20, 2025, the final day of the Fall Clinical Physician Assistant/Nurse Practitioner (PA/NP) Conference took place in Orlando, Florida, bringing together experts to discuss contemporary advancements in dermatology. Jamie Restivo, MPAS, PA-C, provided an overview of critical insights shared during the conference, emphasizing developments in psoriasis treatment, aesthetic innovations, and the significance of patient-centered care.

The conference featured a notable session on psoriatic diseases led by Lauren Miller, PA-C, Director of APP Education for Dermsquared, and TJ Chao, PA-C, a member of the Dermsquared Advisory Board. They presented a comprehensive examination of psoriasis and psoriatic arthritis, covering various clinical phenotypes and associated comorbidities.

Miller and Chao highlighted the burden of obesity as a significant modifiable risk factor that not only exacerbates the severity of psoriasis but also diminishes the effectiveness of systemic therapies. This underscores the importance of weight management in the comprehensive treatment strategy for patients suffering from these conditions. According to Miller, addressing mental health in context with psoriasis is essential, as she stated, "It's crucial to ask patients how their disease affects their daily lives, rather than merely screening for depression and anxiety."

The experts also tackled the social stigma surrounding psoriasis, noting that the public frequently misperceives the disease as contagious. They stressed the urgency of early diagnosis and the necessity of regular screenings to identify joint involvement, emphasizing that while patients may achieve clear skin, irreversible joint damage can occur if left untreated. Miller poignantly remarked, "You can’t unburn the toast," driving home the necessity for proactive management strategies, particularly for patients at risk of developing joint issues.

Chao referred to the current advancements in psoriasis treatments as a "renaissance" in care, despite the fact that many patients remain undertreated. He advocated for a treatment target of achieving a Body Surface Area (BSA) affected of less than 1%. The session concluded with discussions on managing psoriasis during pregnancy and considerations surrounding biologic therapies.

In another session, Heather Gates, PA-C, introduced attendees to emerging innovations in aesthetics. Gates discussed the potential of trenibotulinumtoxinE, a novel wrinkle relaxer that promises quick results without compromising facial expressiveness. This product, targeted at actors and those seeking temporary aesthetic adjustments, was described by Gates as a "toxin for procrastinators."

She further presented a new hybrid filler that combines hyaluronic acid (HA) with calcium hydroxylapatite (CaHA), providing immediate volume restoration alongside long-term skin benefits. This filler was aptly termed a “401(k) for your face,” highlighting its dual advantages of instant gratification and biostimulatory effects.

Additionally, Tanya Patron, PA-C, captivated the audience with her presentation on non-surgical rhinoplasty. She emphasized the importance of anatomical knowledge and safety during procedures, advising clinicians to prioritize patient safety while achieving desirable aesthetic outcomes. Patron described neurotoxin as “training wheels” for dermal fillers, suggesting that combining traditional techniques with modern innovations can enhance patient satisfaction.

Gary Rubin, PA-C, delivered an engaging presentation on the technical aspects of dermal fillers, illustrating complex concepts through everyday objects, thereby making the information accessible to attendees. He concluded his talk by urging practitioners to remain inquisitive and critical in their medical practice.

The conference also featured a panel discussion titled "Pretty Perspectives," where experts shared insights on effective social media practices in aesthetics. They advocated for collaboration over competition, emphasizing that achieving natural results and prioritizing patient health leads to long-term profitability in an increasingly crowded market.

The 2025 Fall Clinical PA/NP Conference underscored the ongoing evolution in dermatological practices and aesthetic medicine, providing valuable insights that practitioners can implement in their clinical settings to enhance patient care and outcomes.

As the field continues to advance, the emphasis on comprehensive patient management, innovative treatment options, and the integration of mental health considerations remains paramount. Future conferences will likely build upon these insights, further shaping the landscape of dermatology and aesthetics in the years to come.